OGI current trades at a 10x P/E 2019 revenue and a 3-4x P/E on FY2020 revenue estimates. We see several near-term catalysts for
The company announced July 15th, it developed a Rapid-Onset Nano-Emulsification Technology for Cannabis Beverages with an initial onset of 10-15 mins vs 60-90 mins on average. The company also clearly told the market they're actively seeking a beverage partner & is for sale.
Management has proven they can execute with positive adjusted EBITDA 4x Qs in a row, minimal dilution to shareholders vs peers, disciplined w/ expenses (No $600M losses here), and a very transparent with investors.
We expect
Time will tell...
***Disclaimer: I am long $OGI. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.***
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。